Magda Bijster
Feb 1, 2007
From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging
Forrer F, Rolleman E, Bijster M, Melis M, Bernard B, Krenning E, de Jong M. From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging. Cancer Biother Radiopharm 2007; 22:40-9.
Feb 1, 2007From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging
Feb 1, 2007Cancer Biother Radiopharm 2007; 22:40-9
Forrer Flavio, Rolleman Edgar, Bijster Magda, Melis Marleen, Bernard Bert, Krenning Eric P, de Jong Marion
more
Dec 5, 2006
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
Rolleman E, Forrer F, Bernard B, Bijster M, Vermeij M, Valkema R, Krenning E, de Jong M. Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate. Eur J Nucl Med Mol Imaging 2006; 34:763-771.
Dec 5, 2006Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
Dec 5, 2006Eur J Nucl Med Mol Imaging 2006; 34:763-771
Rolleman Edgar J, Forrer Flavio, Bernard Bert, Bijster Magda, Vermeij Marcel, Valkema Roelf, Krenning Eric P, de Jong Marion
more